Literature DB >> 6331593

Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters.

J J Frost, H N Wagner.   

Abstract

In order to determine the relationship between in vitro and in vivo binding of opiates in the CNS, the in vitro and in vivo binding properties of 9 opiates, including agonists and antagonists, were studied in mouse brain. Equilibrium dissociation constants (KD) were measured in the presence and absence of 100 mM NaCl and 100 microM 5-guanylylimidodiphosphate (GMP-PNP) at 37 degrees C in mouse brain homogenates. The rate constants describing the exponential clearance of the specifically-bound (i.e. receptor-bound) fraction of ligand in vivo were measured in the striatum, thalamus and cortex. A mathematical model was formulated which relates the in vivo clearance rate for the specifically-bound fraction to the association and dissociation rate constants, the local density of receptors and a parameter which determines the rate at which ligand can diffuse out of the local receptor compartment. The diffusion parameter takes on two forms depending on whether ligand is transported out of the local receptor compartment by simple diffusion or by permeation of a non-polar membrane barrier. In the case of membrane permeation, the model is dependent on the diffusion constant and the lipophilicity of the ligand. A correlation between the in vitro and in vivo measurements is obtained only when KD is measured in the presence of 100 mM NaCl and 100 microM GMP-PNP and when the lipophilicity of the ligand is incorporated into the model. The model corresponds to the physical situation where continuous rebinding of ligand to receptors takes place in the vicinity of a high local density of receptors (possibly at a synapse), thereby retarding the clearance of the specifically-bound ligand from the brain. The rebinding effect is accentuated by: (1) a high local density of receptors; (2) a small KD (measured in the presence of 100 mM NaCl and 100 microM GMP-PNP); (3) a low lipophilicity; and (4) a high molecular weight.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331593     DOI: 10.1016/0006-8993(84)91113-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Design, synthesis and evaluation of 111In labeled DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors.

Authors:  John R Lever; Emily A Fergason-Cantrell; Terry L Carmack; Lisa D Watkinson; Fabio Gallazzi
Journal:  Nucl Med Biol       Date:  2019-03-07       Impact factor: 2.408

3.  Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction.

Authors:  B R Zeeberg; H N Wagner
Journal:  Bull Math Biol       Date:  1987       Impact factor: 1.758

Review 4.  Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

5.  Effects of target binding kinetics on in vivo drug efficacy: koff , kon and rebinding.

Authors:  Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

Review 6.  Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo.

Authors:  Georges Vauquelin
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

7.  Approaches to quantify radioligands that wash out slowly from target organs.

Authors:  Jussi Hirvonen; Garth E Terry; Christer Halldin; Victor W Pike; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05       Impact factor: 9.236

8.  Theoretical effects of radioligand diffusional gradients and microscopic neuroreceptor distribution in in vivo kinetic studies.

Authors:  B R Zeeberg; R C Reid; K A Murphy; R C Reba
Journal:  Bull Math Biol       Date:  1988       Impact factor: 1.758

9.  In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors.

Authors:  Tetsuya Tsujikawa; Sami S Zoghbi; Jinsoo Hong; Sean R Donohue; Kimberly J Jenko; Robert L Gladding; Christer Halldin; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  Neuroimage       Date:  2013-09-25       Impact factor: 6.556

10.  Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand.

Authors:  Garth E Terry; Jeih-San Liow; Sami S Zoghbi; Jussi Hirvonen; Amanda G Farris; Alicja Lerner; Johannes T Tauscher; John M Schaus; Lee Phebus; Christian C Felder; Cheryl L Morse; Jinsoo S Hong; Victor W Pike; Christer Halldin; Robert B Innis
Journal:  Neuroimage       Date:  2009-06-30       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.